The largest database of trusted experimental protocols

2 protocols using pf 4708671

1

Lymphocyte Isolation and Lipid Mediator Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocyte separation medium, aprotinin, dimethyl sulfoxide (DMSO) and solvents for HPLC and LC/MS were purchased from Thermo Fisher Scientific (Ottawa, Ontario, Canada). Dextran, adenosine deaminase, leupeptin and potassium phosphate were obtained from Sigma-Aldrich Canada (Oakville, Ontario, Canada). HBSS was purchased from Wisent Bioproducts (St-Bruno, Quebec, Canada). 19-OH-prostaglandin (PG) B2, PGB2, PGB2-D4 and 17-octadecynoic acid (17-ODYA) were purchased from Cayman Chemicals (Ann Arbor, Michigan, USA). PF-4708671 was obtained from Abcam (Cambridge, Massachusetts, USA) and LY2584702 from Selleckchem (Houston, Texas, USA). Thapsigargin was obtained from Tocris Bioscience (Ellisville. Missouri, USA). LTB4 was a generous gift from Dr Louis Flamand (Université Laval, Québec City, Canada). Recombinant CYP4F3A and the NADPH regenerating system were purchased from Corning (Corning, New York, USA). Protease and phosphatase inhibitor cocktail tablets were purchased from Roche (Laval, Quebec, Canada). Primary (anti-phospho-S6 #2211 and anti-S6 #2317) and secondary antibodies were obtained from Cell Signaling (Danvers, Massachusetts, USA). The enhanced chemiluminescent (ECL) substrate was obtained from Millipore Canada Ltd (Toronto, Ontario, Canada).
+ Open protocol
+ Expand
2

Mesothelioma Cell Lines for Drug Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mesothelioma cells, NCI‐H28, NCI‐H226, MSTO‐211H and NCI‐H2452, and immortalized cells of mesothelium origin, Met‐5A, were purchased from American Type Culture Collection (Manassas, VA, USA). Mesothelioma with mutated p53 genotype, EHMES‐1 and JMN‐1B cells were provided by Dr. Hironobu Hamada (Hiroshima University, Japan) (Nakataki et al., 2006). PEM‐resistant H28‐PEM, H226‐PEM, 211H‐PEM, and H2452‐PEM cells were previously established from the respective parent cells by a stepwise increase of PEM. CDDP‐resistant NCI‐H28, MSTO‐211H and NCI‐H2452 cells were also established with the same method (Kitazono‐Saitoh et al., 2012). Cells were cultured with RPMI‐1640 medium supplemented with 10% fetal calf serum and confirmed to be negative for mycoplasma. The genotype of p53 was wild‐type in NCI‐H28, NCI‐H226, MSTO‐211H and NCI‐H2452 cells, but p53 protein of NCI‐H2452 cells was truncated (Di Marzo et al., 2014). Chemicals used in the present study were purchased as follows: PEM (Eli Lilly, Indianapolis, IN, USA), A769662 (Catalogue number: ab120335), PF4708671 (ab141993), compound C (ab120843, Abcam, Cambridge, UK), nutlin‐3a (S8059, Selleck, Houston, TX, USA), MK‐2206 (CT‐MK2206, ChemieTek, Indianapolis, IN, USA) and rapamycin (R8781, Sigma‐Aldrich, St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!